相关实验视频

Updated: May 31, 2025

Author Spotlight: Developing a Rat Model for Weight-Bearing Intervention to Investigate Osteonecrosis of the Femoral Head

Author Spotlight: Developing a Rat Model for Weight-Bearing Intervention to Investigate Osteonecrosis of the Femoral Head

Published on: September 27, 2024

葡萄糖皮质类药物对系统性红斑狼小鼠骨重塑的影响

Sheng Hao¹, Yuyun Zhang¹, Xiaowei Tong¹

¹Department of Nephrology, Rheumatology and Immunology, Shanghai Children's Hospital, School of medicine, Shanghai Jiao Tong University, Shanghai, China.

Pediatric research

|January 24, 2025

概括

葡萄糖皮质类药物在狼小鼠模型中加剧了骨密度损失,影响骨结构和RANKL/OPG等重塑标志物. 狼和这些药物都会导致异常的骨变化.

科学领域:

骨生物学和风湿病学研究.
研究自身免疫性疾病的骨并发症.

背景情况:

系统性红斑狼 (SLE) 管理通常涉及葡萄糖皮质类药物.
葡萄糖皮质类药物可能会对骨健康产生负面影响.
在SLE背景下了解这些影响至关重要.

研究的目的:

在SLE小鼠模型中研究葡萄糖皮质激素对骨的影响.
分析骨矿物质密度 (BMD),微观结构和重塑标记物的变化.

主要方法:

MRL/lpr (SLE模型) 和C57BL/6小鼠接受了德克萨米他或盐水4周.
骨评估包括骨质量,骨结构分析和血清RANKL/OPG水平.

主要成果:

德克萨米他降低了两个小鼠菌株的骨质量和改变了骨厚度.
皮层和椎骨的骨重塑在不同菌株之间受到不同的影响.
葡萄糖皮质类药物增加了RANKL,降低了OPG,在SLE模型中加剧了骨损失.

结论:

葡萄皮质类药物和SLE都会导致异常的骨重塑.
RANKL/OPG通路与SLE中葡萄糖皮质类药物诱导的骨变化有关.
葡萄糖皮质类药物显著改变了由炎症调节的骨参数.

更多相关视频

The bm12 Inducible Model of Systemic Lupus Erythematosus SLE in C57BL/6 Mice

The bm12 Inducible Model of Systemic Lupus Erythematosus SLE in C57BL/6 Mice

Published on: November 1, 2015

Preparation Of Gushukang GSK Granules for In Vivo and In Vitro Experiments

Preparation Of Gushukang GSK Granules for In Vivo and In Vitro Experiments

Published on: May 9, 2019

相关概念视频

Bone Remodeling

Bone Remodeling

Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.